Capital Flow Monitor · Sponsors · CIK 1833214
SAB Biotherapeutics, Inc.
777 W 41st St, Miami Beach, FL, 33140 · 305 845-2813
Biotechnology · Corporation· inc. DELAWARE true 2020
Fit score
—
Offering
$175.0M
Sold
$175.0M
% sold
100.0%
Investors
17
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-08-05 | D ·current | 506(b) | $175.0M | $175.0M | 100.0% | 17 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Samuel Reich — Executive Officer / Director, Miami Beach, FL
- Eddie Sullivan — Executive Officer / Director, Miami Beach, FL
- Katie Ellias — Director, Miami Beach, FL
- Scott Giberson — Director, Miami Beach, FL
- Christine Hamilton — Director, Miami Beach, FL
- David Link — Director, Miami Beach, FL
- Erick Lucera — Director, Miami Beach, FL
- Andrew Moin — Director, Miami Beach, FL
- William Polvino — Director, Miami Beach, FL
- Jay Skyler — Director, Miami Beach, FL
- Jeffrey Spragens — Director, Miami Beach, FL
Placement agents
- Ubs Securities Llc · 1 RE raises
- Oppenheimer & Co., Inc. · 0 RE raises
- Chardan Capital Markets, Llc · 0 RE raises
- Leerink Partners Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.